Your browser doesn't support javascript.
loading
Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach.
Tosca, Elena M; Gauderat, Glenn; Fouliard, Sylvain; Burbridge, Mike; Chenel, Marylore; Magni, Paolo.
Afiliación
  • Tosca EM; Laboratory of Bioinformatics, Mathematical Modelling and Synthetic Biology, Department of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Pavia, Italy.
  • Gauderat G; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France.
  • Fouliard S; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France.
  • Burbridge M; Center for Therapeutic Innovation in Oncology, Servier, Suresnes, France.
  • Chenel M; Clinical Pharmacokinetics and Pharmacometrics Division, Servier, Suresnes, France.
  • Magni P; Laboratory of Bioinformatics, Mathematical Modelling and Synthetic Biology, Department of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Pavia, Italy.
CPT Pharmacometrics Syst Pharmacol ; 10(11): 1396-1411, 2021 11.
Article en En | MEDLINE | ID: mdl-34708556
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: CPT Pharmacometrics Syst Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Italia